Teprotumumab Efficacy, Safety and Durability in Longer Duration Thyroid Eye Disease and Retreatment: Optic-X Study.
暂无分享，去创建一个
Terry J. Smith | R. Holt | C. Marcocci | G. Kahaly | D. Führer-Sakel | A. Antonelli | H. Elflein | S. Sile | J. Schiffman | A. Eckstein | Shoaib Ugradar | M. Marinò | R. Douglas | R. Tang | M. Francis-Sedlak | B. Fowler | K. Ponto | M. Salvi | R. Dailey | S. Wester | G. Harris | A. P. Jain | Raymond S. Douglas